Licarbazepine-d8
Licarbazepine-d8 (BIA 2-005-d8) is deuterium labeled Licarbazepine. Licarbazepine (BIA 2-005; GP 47779) ?is a?voltage-gated sodium channel?blocker?with?anticonvulsant?and?mood-stabilizing?effects[1].
Product Specifications
CAS Number
1261393-17-2
Product Name Alternative
BIA 2-005-d8; GP 47779-d8
UNSPSC
12352005
Target
Isotope-Labeled Compounds; Sodium Channel
Related Pathways
Membrane Transporter/Ion Channel; Others
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
NC(N1C2=C([2H])C([2H])=C([2H])C=C2C(C([2H])([2H])C3=CC([2H])=C([2H])C([2H])=C31)O)=O
Molecular Formula
C15H6D8N2O2
Molecular Weight
262.33
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Rajinder P Singh, et al. A review of eslicarbazepine acetate for the adjunctive treatment of partial-onset epilepsy. J Cent Nerv Syst Dis. 2011 Jul 20;3:179-87.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
